![](/img/cover-not-exists.png)
Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis
Vaddi, Kris, Sarlis, Nicholas J, Gupta, VikasVolume:
13
Language:
english
Journal:
Expert Opinion on Pharmacotherapy
DOI:
10.1517/14656566.2012.732998
Date:
November, 2012
File:
PDF, 545 KB
english, 2012